This is the authors' abstract. We don't add key points for this paper.
In celiac disease, intestinal transglutaminase (TG2) produces immunogenic peptides by deamidation of gluten proteins. These products drive the celiac immune response. We have previously identified an interaction between gliadin and a food additive, E304i, which prevents gliadin processing (both deamidation and transamidation) by TG2,
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Engström et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: